BINOSTO (alendronate sodium)


Drug overview for BINOSTO (alendronate sodium):

Generic name: alendronate sodium (a-LEN-droe-nate)
Drug class: Osteoporosis Agents
Therapeutic class: Endocrine

Alendronate sodium, a synthetic bisphosphonate analog of pyrophosphate, is a bone resorption inhibitor.

No enhanced Uses information available for this drug.
DRUG IMAGES
  • BINOSTO 70 MG EFFERVESCENT TAB
    BINOSTO 70 MG EFFERVESCENT TAB
The following indications for BINOSTO (alendronate sodium) have been approved by the FDA:

Indications:
Osteoporosis in male patient
Postmenopausal osteoporosis


Professional Synonyms:
Osteoporosis in men
Post-menopausal osteoporosis